These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 31704082)
1. An EEG marker of reward processing is diminished in Parkinson's disease. Brown DR; Richardson SP; Cavanagh JF Brain Res; 2020 Jan; 1727():146541. PubMed ID: 31704082 [TBL] [Abstract][Full Text] [Related]
2. Dissociating the contributions of reward-prediction errors to trial-level adaptation and long-term learning. Lohse KR; Miller MW; Daou M; Valerius W; Jones M Biol Psychol; 2020 Jan; 149():107775. PubMed ID: 31563586 [TBL] [Abstract][Full Text] [Related]
3. The reward positivity is sensitive to affective liking. Brown DR; Jackson TCJ; Cavanagh JF Cogn Affect Behav Neurosci; 2022 Apr; 22(2):258-267. PubMed ID: 34599487 [TBL] [Abstract][Full Text] [Related]
4. Gambling behavior in Parkinson's Disease: Impulsivity, reward mechanism and cortical brain oscillations. Balconi M; Angioletti L; Siri C; Meucci N; Pezzoli G Psychiatry Res; 2018 Dec; 270():974-980. PubMed ID: 29580652 [TBL] [Abstract][Full Text] [Related]
7. Psychophysiological evidence for impaired reward anticipation in Parkinson's disease. Mattox ST; Valle-Inclán F; Hackley SA Clin Neurophysiol; 2006 Oct; 117(10):2144-53. PubMed ID: 16920018 [TBL] [Abstract][Full Text] [Related]
8. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease. Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420 [TBL] [Abstract][Full Text] [Related]
9. Neural mechanisms underlying cognitive inflexibility in Parkinson's disease. Lange F; Seer C; Loens S; Wegner F; Schrader C; Dressler D; Dengler R; Kopp B Neuropsychologia; 2016 Dec; 93(Pt A):142-150. PubMed ID: 27693667 [TBL] [Abstract][Full Text] [Related]
10. Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease. van der Vegt JP; Hulme OJ; Zittel S; Madsen KH; Weiss MM; Buhmann C; Bloem BR; Münchau A; Siebner HR Brain; 2013 Apr; 136(Pt 4):1192-203. PubMed ID: 23442226 [TBL] [Abstract][Full Text] [Related]
11. Identification of an early-stage Parkinson's disease neuromarker using event-related potentials, brain network analytics and machine-learning. Hassin-Baer S; Cohen OS; Israeli-Korn S; Yahalom G; Benizri S; Sand D; Issachar G; Geva AB; Shani-Hershkovich R; Peremen Z PLoS One; 2022; 17(1):e0261947. PubMed ID: 34995285 [TBL] [Abstract][Full Text] [Related]
12. Functional inhibitory control dynamics in impulse control disorders in Parkinson's disease. Paz-Alonso PM; Navalpotro-Gomez I; Boddy P; Dacosta-Aguayo R; Delgado-Alvarado M; Quiroga-Varela A; Jimenez-Urbieta H; Carreiras M; Rodriguez-Oroz MC Mov Disord; 2020 Feb; 35(2):316-325. PubMed ID: 31710401 [TBL] [Abstract][Full Text] [Related]
13. Reduced positive affect alters reward learning via reduced information encoding in the Reward Positivity. Jackson TCJ; Cavanagh JF Psychophysiology; 2023 Aug; 60(8):e14276. PubMed ID: 36807324 [TBL] [Abstract][Full Text] [Related]
17. Reward processing in health and Parkinson's disease: neural organization and reorganization. Goerendt IK; Lawrence AD; Brooks DJ Cereb Cortex; 2004 Jan; 14(1):73-80. PubMed ID: 14654458 [TBL] [Abstract][Full Text] [Related]
18. Impulse Control Disorders in Parkinson's Disease are Associated with Alterations in Reward-Related Cortical Oscillations. Carriere N; Bourriez JL; Delval A; Derambure P; Defebvre L; Dujardin K J Parkinsons Dis; 2016 Jun; 6(3):651-66. PubMed ID: 27372215 [TBL] [Abstract][Full Text] [Related]
19. Effects of asymmetric dopamine depletion on sensitivity to rewarding and aversive stimuli in Parkinson's disease. Maril S; Hassin-Baer S; Cohen OS; Tomer R Neuropsychologia; 2013 Apr; 51(5):818-24. PubMed ID: 23422331 [TBL] [Abstract][Full Text] [Related]
20. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study. Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]